Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop

Neurology

Volumn 47, Issue 1, 1996, Pages 1-9

  Litvan, I ^a   Agid, Y ^b   Calne, D ^b   Campbell, G ^b   Dubois, B ^b   Duvoisin, R C ^b   Goetz, C G ^b   Golbe, L I ^b   Grafman, J ^b   Growdon, J H ^b   Hallett, M ^b   Jankovic, J ^b   Quinn, N P ^b   Tolosa, E ^b   Zee, D S ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BODY POSTURE; CLINICAL FEATURE; COGNITIVE DEFECT; DYSARTHRIA; ETIOLOGY; EYE MOVEMENT; FALLING; NEUROFIBRILLARY TANGLE; NEUROPIL; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SACCADIC EYE MOVEMENT; VISUAL DISORDER;

EID: 8944226575     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.47.1.1     Document Type: Review

References (88)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
2. Steele JC. Progressive supranuclear palsy. Brain 1972;95: 693-704.
3. Steele JC. Introduction. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:3-14.
4. Posey WC. Analysis of the upward movements of the eyes. Ann Ophthalmol 1904;13:523-529.
5. Spiller WG. The importance in clinical diagnosis of paralysis of associated movements of the eyeballs (Blick-Laehmung), especially of upward and downward associated movements. J Nerv Ment Dis 1905;32:417-531.
6. Lees AJ. Foreward. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:vi-x.
7. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 1988;38:1031-1034.
8. Golbe LI. The epidemiology of PSP. J Neural Transm Suppl 1994;42:263-273.
9. Golbe LI. Epidemiology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:33-43.
10. Hauw J-J, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44: 2015-2019.
11. Litvan I, Hauw J-J, Bartko JJ, et al. Validity and reliability of the neuropathologic preliminary criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
12. Probst A, Langui D, Lautenschlager C, Ulrich J, Brion JP, Anderton BH. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol (Berl) 1988;77:61-68.
13. Jellinger KA, Bancher C. Neuropathology. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:44-88.
14. Lantos PL. The neuropathology of progressive supranuclear palsy. J Neural Transm Suppl 1994;42:137-152.
15. Hauw J-J, Verny M, Mokhtari K, et al. Neuropathologic diagnostic criteria of Steele-Richardson-Olszewski disease (progressive supranuclear palsy) for brain banking purposes. In: Cruz-Sánchez FF, Ravid R, Cuzner ML, eds. Neuropathological diagnostic criteria for brain banking. Amsterdam: IOS Press, 1995:80-88.
16. Gearing M, Olson DA, Watts RL, Mirra SS. Progressive supranuclear palsy: neuropathologic and clinical heterogeneity. Neurology 1994;44:1015-1024.
17. Will RG, Lees AJ, Gibb W, Barnard RO. A case of progressive subcortical gliosis presenting clinically as Steele-Richardson-Olszewski syndrome. J Neurol Neurosurg Psychiatry 1988;51: 1224-1227.
18. Gibb WR, Luthert PJ, Marsden CD. Corticobasal degeneration. Brain 1989;112:1171-1192.
19. Dubinsky RM, Jankovic J. Progressive supranuclear palsy and a multi-infarct state. Neurology 1987;37:570-576.
20. Winikates J, Jankovic J. Vascular progressive supranuclear palsy. J Neural Transm Suppl 1994;42:189-201.
21. Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 1991;54:159-161.
22. De Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord 1992;7:355-358.
23. Foster NL, Gilman S, Berent S, et al. Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. J Neurol Neurosurg Psychiatry 1992;55:707-713.
24. Jankovic J, Rajput AH, Golbe LI, Goodman JC. What is it? Case 1, 1993: parkinsonism, dysautonomia, and ophthalmopa resis. Mov Disord 1993;8:525-532.
25. Revesz T, Daniel SE, Lees AJ, Will RG. A case of progressive subcortical gliosis associated with deposition of abnormal prion protein. J Neurol Neurosurg Psychiatry 1995; in press.
26. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930.
27. Jackson JA, Jankovic J, Ford J. Progressive supranuclear palsy: clinical features and response to treatment in 16 patients. Ann Neurol 1983;13:273-278.
28. Boller F, Lopez OL, Moossy J. Diagnosis of dementia: clinicopathologic correlations. Neurology 1989;39:76-79.
29. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991;18:275-278.
30. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
31. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 46-1993. A 75-year-old man with right-sided rigidity, dysarthria, and abnormal gait. N Engl J Med 1993;329:1560-1567.
32. Litvan I, Chase TN. Traditional and experimental therapeutic approaches. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy, clinical and research approaches. New York: Oxford University Press, 1992:254-269.
33. Lees AJ. The Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). In: Marsden CD, Fahn S, eds. Movement disorders 2. London: Butterworths, 1987:272-287.
34. Blin J, Baron JC, Dubois B, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations. Arch Neurol 1990;47:747-752.
35. Golbe LI, Davis PH. Progressive supranuclear palsy. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins, 1993:145-161.
36. Duvoisin RC. Clinical diagnosis. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:15-33.
37. Tolosa E, Valldeoriola F, Marti MJ. Clinical diagnosis and diagnostic criteria of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neural Transm Suppl 1994;42:15-31.
38. Collins SJ, Ahlskog JE, Parisi JE, Maraganore DM. Progressive supranuclear palsy: neuropathologically based diagnostic criteria. J Neurol Neurosurg Psychiatry 1995;58:167-173.
39. Brusa A, Mancardi GL, Bugiani O. Progressive supranuclear palsy 1979: an overview. Ital J Neurol Sci 1980;4:205-222.
40. De Bruin VM, Lees AJ. Subcortical neurofibrillary degeneration presenting as Steele-Richardson-Olszewski and other related syndromes: a review of 90 pathologically verified cases. Mov Disord 1994;9:381-389.
41. Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease. Arch Neurol 1995;52:294-298.
42. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathologic study. J Neurol Neurosurg Psychiatry 1996 (in press).
43. Troost B. Neuro-ophthalmological aspects. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:44-88.
44. Troost B, Daroff R. The ocular motor defects in progressive supranuclear palsy. Ann Neurol 1977;2:397-403.
45. Cardoso FEC, Jankovic J. Progressive supranuclear palsy. In: Calne DB, ed. Neurodegenerative disorders. Philadelphia: W.B. Saunders, 1994:769-786.
46. Brown J, Lantos P, Stratton M, Roques P, Rossor M. Familial progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1993;56:473-476.
47. Tetrud JW, Golbe LI, Forno LS, Farmer PM. Autopsy-proven progressive supranuclear palsy in two siblings. Neurology 1996;46:931-934.
48. Masliah E, Hansen L, Quijada S, et al. Late onset dementia with argyrophylic grains and subcortical tangles or atypical progressive supranuclear palsy? Ann Neurol 1991;29:389-396.
49. Nuwer MR. Progressive supranuclear palsy despite normal eye movements. Arch Neurol 1981;38:784.
50. Dubas F, Gray F, Escourolle R. Steele-Richardson-Olszewski disease without ophthalmoplegia. Six clinico-anatomic cases. Rev Neurol (Paris) 1983;139:407-416.
51. Pfaffenbach DD, Layton DDJ, Kearns TP. Ocular manifestations in progressive supranuclear palsy. Am J Ophthalmol 1972;74:1179-1184.
52. Davis PH, Bergeron C, McLachlan DR. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985;17:337-343.
53. Matsuo H, Takashima H, Kishikawa M, et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1991;54:397-400.
54. Mizusawa H, Mochizuki A, Ohkoshi N, Yoshizawa K, Kanazawa I, Imai H. Progressive supranuclear palsy presenting with pure akinesia. Adv Neurol 1993;60:618-621.
55. Riley DE, Fogt N, Leigh RJ. The syndrome of 'pure akinesia' and its relationship to progressive supranuclear palsy. Neurology 1994;44:1025-1029.
56. Daniel SE, De Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy) - a reappraisal. Brain 1995; in press.
57. Verny M, Jellinger KA, Hauw J-J, Bancher C, Litvan I, Agid Y. Progressive supranuclear palsy. A clinicopathological study of 21 cases. Acta Neuropathol, in press.
58. Albert ML, Feldman RG, Willis AL. The 'subcortical dementia' of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1974;37:121-130.
59. Cambier J, Masson M, Viader F, Limodin J, Strube A. Frontal syndrome of progressive supranuclear palsy. Rev Neurol (Paris) 1985;141:528-536.
60. Grafman J, Litvan I, Gomez C, Chase TN. Frontal lobe function in progressive supranuclear palsy. Arch Neurol 1990;47: 553-558.
61. Pillon B, Dubois B. Cognitive and behavioral impairments. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:223-240.
62. Litvan I. Cognitive disturbances in progressive supranuclear palsy. J Neural Transm Suppl 1994;42:69-78.
63. Ghika J, Tennis M, Growdon J, Hoffman E, Johnson K. Environment-driven responses in progressive supranuclear palsy. J Neurol Sci 1995;130:104-111.
64. D'Antona R, Baron JC, Samson Y, et al. Subcortical dementia. Frontal cortex hypometabolism detected by positron tomography in patients with progressive supranuclear palsy. Brain 1985;108:785-799.
65. 76Br] bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy. J Cereb Blood Flow Metab 1986;6:131-136.
66. Foster NL, Gilman S, Berent S, Morin EM, Brown MB, Koeppe RA. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography. Ann Neurol 1988;24:399-406.
67. Leenders KL, Frackowiak RS, Lees AJ. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain 1988;111:615-630.
68. Goffinet AM, De Volder AG, Gillain C, et al. Positron tomography demonstrates frontal lobe hypometabolism in progressive supranuclear palsy. Ann Neurol 1989;25:131-139.
69. 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Ann Neurol 1990;28:547-555.
70. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
71. 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994;57:278-284.
72. Blin J, Horwitz B, Baron J, Agid Y. Does frontal cortex hypometabolism in progressive supranuclear palsy result from subcortical dysfunction? Eur J Neurol 1995;1:221-228.
73. Pierrot-Deseilligny C, Turell E, Penet C, et al. Increased wave P300 latency in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1989;52:656-658.
74. Johnson RJ, Litvan I, Grafman J. Progressive supranuclear palsy: altered sensory processing leads to degraded cognition. Neurology 1991;41:1257-1262.
75. Johnson RJ. Event-related brain potentials. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:122-154.
76. Vidailhet M, Rothwell JC, Thompson PD, Lees AJ, Marsden CD. The auditory startle response in the Steele-Richardson-Olszewski syndrome and Parkinson's disease. Brain 1992;115: 1181-1192.
77. Rothwell JC, Vidailhet M, Thompson PD, Lees AJ, Marsden CD. The auditory startle response in progressive supranuclear palsy. J Neural Transm Suppl 1994;42:43-50.
78. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol 1994;35:420-426.
79. Masucci EF, Borts FT, Smirniotopoulos JG, Kurtzke JF, Schellinger D. Thin-section CT of midbrain abnormalities in progressive supranuclear palsy. AJNR Am J Neuroradiol 1985;6:767-772.
80. Schonfeld SM, Golbe LI, Sage JI, Safer JN, Duvoisin RC. Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade. Mov Disord 1987;2:263-278.
81. Savoiardo M, Girotti F, Strada L, Cieri E. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. J Neural Transm Suppl 1994;42:93-110.
82. Laffont F, Autret A, Minz M, et al. Polygraphic study of nocturnal sleep in three degenerative diseases: ALS, oligo-ponto-cerebellar atrophy, and progressive supranuclear palsy. Waking Sleeping 1979;3:17-30.
83. Perret JL, Jouvet M. Sleep study of progressive supranuclear paralysis. Electroencephalogr Clin Neurophysiol 1980;49:323-329.
84. Aldrich MS, Foster NL, White RF, Bluemlein L, Prokopowicz G. Sleep abnormalities in progressive supranuclear palsy. Ann Neurol 1989;25:577-581.
85. Aldrich MS. Sleep disturbances. In: Litvan I, Agid Y, eds. Progressive supranuclear palsy: clinical and research approaches. New York: Oxford University Press, 1992:169-183.
86. Fahn S, Elton RL, members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A, eds. Recent developments in Parkinson' disease, Vol. II. Florham Park, NJ: Macmillan Health Care Information, 1987:153-163.
87. Grafman J, Litvan I, Stark M. Neuropsychological features of progressive supranuclear palsy. Brain Cogn 1995;2:311-320.
88. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.